HypertensionOS

U.S. Food and Drug Administration Selects Three Participants in Digital Health Device Pilot Program

The FDA selected three manufacturers to participate in the TEMPO pilot program, which aims to expand access to digital health devices intended to improve outcomes for patients with chronic diseases under the ACCESS model. The companies will collect real-world use data, while the FDA has not yet evaluated the effectiveness of the devices for the specific uses covered by the program.